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A novel group of small non-coding RNA, known as microRNA (miRNA) is predicted to regulate
as high as 90% of the coding genes in human. The diversity and abundance of miRNA targets offer
an enormous level of combinatorial possibilities and suggest that miRNAs and their targets form
a complex regulatory network. In the present study, we analyzed 711 miRNAs and their 34, 525
predicted targets in the miRBase database (http://microrna.sanger.ac.uk/, version 10 ), which gen-
erate a complex bipartite network having numerous numbers of genes forming the hub. Genes
at the hub (total 9877) are significantly over represented in genes with specific molecular func-
tions, biological processes and biological pathways as revealed from the analysis using PANTHER
(http://www.pantherdb.org/genes/). We further construct a miRNA co-target network by linking
every pair of miRNAs which co-target at least one gene. The weight of the link, which is taken to be
the number of co-targets of the pair of miRNAs vary widely, and we could erase several links while
keeping the relevant features of the network intact. The largest connected sub-graph, thus obtained,
contains 479 miRNAs. More than 75% of the miRNAs deregulated in 15 different diseases collected
from published data are found to be in this largest sub graph. We further analyze this sub-graph to
obtain 70 small clusters containing total 330 miRNAs of 479. We identified the biological pathways
where the co-targeted genes in the clusters are significantly over- represented in comparison to that
obtained with that are not co-targeted by the miRNAs in the cluster. Using published data, we
identified that specific clusters of miRNAs are associated with specific diseases by altering particular
pathways. We propose that instead of single miRNA, clusters of miRNA that co-targets the genes
are important for the regulation of miRNA in diseases.
I. INTRODUCTION
Micro-RNA (miRNA) belongs to a class of small
non-coding single stranded RNA, approximately 21 nu-
cleotides long, which negatively regulate gene expres-
sions. Mature miRNA interacts with the 3′ untrans-
lated regions (3′ UTR) of the gene in human and down
regulate the expression of the target either by degrad-
ing the mRNA or inhibiting the translation. In some
cases, increased expressions of the target gene by miR-
NAs have also been reported (reviewed in [1]). Recent
experiments show, at least in few specific cases, that the
mature miRNA can alters the expressions of the genes
by binding to the coding regions as well as 5′ UTR of
genes [2-4] providing further complex regulation of the
genes by miRNAs. It has been proposed on the basis of
theoretical analysis that as many as 30% of genes in the
human genome may be the target of miRNA [5]. Re-
cent, estimates predict that as large as 90% human genes
are targets of miRNA [6]. However, experimental vali-
dation of such prediction is largely lacking. Function of
each region of the mature miRNA is not well defined, al-
though, the seed region (2nd to 7th position from the 5′
end of the mature miRNA), is the most important region
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that interacts with 3′ UTR for regulation of the target
genes. The other regions known as extended seed and
delta seed regions also contribute to the target selection
[7]. The diversity and abundance of miRNA targets of-
fer an enormous level of combinatorial possibilities and
suggest that miRNAs and their targets appear to form a
complex regulatory network.
Functions of miRNA is known only for some, although
deregulation of miRNAs has been shown in number of
diseases like various types of cancers [8, reviewed in 9]
cardiovascular development and heart failure [10]. In-
volvement of miRNAs in various diseases has been re-
cently reviewed [11]. Studies of various diseases and nor-
mal cellular processes indicate that miRNAs are involved
in immune-system [12]; stem cell renewal and develop-
ment [13, 14]. Using inhibitors of different miRNAs it
has also been shown that several miRNAs are involved
in cell death, cell growth and proliferation [15]. The ex-
tent of modulation of the targets and their influences on
the biological processes that lead to alteration of cellular
phenotype varies considerably [16]. In a recent study in
Caenorhabiditis elegans (C. elegans) where 83% of the
C. elegans miRNA (total 95 miRNA) are mutated and
effects of these mutant genes are studied. It is shown
that majority of miRNA mutations do not result into any
phenotypic changes, indicating that there are redundan-
cies of miRNAs that can target a gene. However, 10% of
miRNA deletion causes clear developmental and morpho-
logical defects. It has been proposed that there is signif-
2icant functional redundancy among miRNAs or among
gene pathways regulated by miRNAs [17]. In spite of
considerable information on the involvement of miRNA
in numerous biological processes and large number of hu-
man diseases, the precise information of the targets they
regulate in the normal processes and diseases remains
elusive.
Role of miRNAs in signal transduction pathway has
been identified in a recent work. By analyzing the in-
teractions between miRNAs and a human cellular signal-
ing network, it has been observed that miRNAs specifi-
cally target positive regulatory motifs, downstream net-
work components and the highly connected scaffolds in a
signaling network and genes whose promoter regions in-
clude a large number of putative transcription factor(TF)
binding sites [18]. Combinatorial regulation of genes by
TF and miRNAs provides higher complex programs [19].
However, it is not known fully how miRNA-miRNA in-
teractions regulates the expressions of the genes. Inter-
actions of miRNA-miRNA and miRNA-TF in regulat-
ing the expressions of protein coding genes have recently
been studied. Two databases namely Target Scan and
PicTar have been used that cataloged 8672 predicted tar-
gets of 138 miRNA and 9152 predicted targets of 178
miRNA respectively. There are overlaps ( 80%) in the
miRNA lists and targets covered in these two databases
[20]. Abilities of three miRNA namely miR-16, miR-
34a, miR-106b to alter cell cycle, target expressions and
apoptosis have been studied. It has been observed that
miR-16 and miR-34a together block G1 to S transition
greater than that obtained individually but lesser than
additive. On the contrary, expression of miR-106b, which
accelerates G1 to S transition, together with miR-16 or
miR-34a, reduce the cells in G1 less than that obtained
with miR-16 or miR-34a alone but higher that obtained
with miR-106b alone. This result shows that miR-16 and
miR-34a together exhibit an intermediate cellular pheno-
type. All these miRNAs alter specific sets of the targets.
Thus different miRNA may target the different proteins
in the same pathways [21]. Experimental evidence also
has been provided recently to show that specific pairs of
miRNAS together involves in the maintenance of embry-
onic stem cells [22]. It is important to know whether
miRNAs interact in a combinatorial fashion, alters spe-
cific biological pathway(s) and participates in human dis-
eases.
In the present communication, using 711 miRNA in
human and their predicted targets we have performed a
topological analysis of miRNA network to elucidate how
miRNA-miRNA interactions regulate the targets. We ob-
serve that the miRNA are clustered and that some clus-
ters of miRNA co-target the genes in the specific path-
ways. Analysis of published experimental data describing
deregulated miRNA and mRNA in 15 diseases, support
this notion.
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miRNAs
Gene targets
Figure 1: Figure shows a schematic representation of the
bipartite connections of miRNAS and their targets.
II. RESULTS AND DISCUSSIONS
A. Connectivity in miRNA- gene interaction
network
For the analysis of miRNA and their tar-
gets in human, we use the miRBase database,
(http://microrna.sanger.ac.uk/) which has M = 711
microRNAs (miRNAs) and N = 34525 gene targets.
First, a data set is created where the gene versus the
set of miRNAs targeting that particular gene is listed
row-wise. A schematic representation of the data set
as a bi-partite network is shown in Figure 1. The
blue and red circles there represent the miRNAs and
the genes respectively. For convenience, both miRNAs
and genes are given arbitrary identification number
m = 1, 2, . . . i, . . .M and n = 1, 2, . . . j, . . . N respec-
tively. A line (or link) is drawn between micro RNA i
and a gene j, if i targets j. In total there are 676265
links which connect the miRNAs and their targets. From
the figure it is evident that the system of miRNA-gene
form a bi-partite network represented by a (M × N)
adjacency matrix A with matrix elements,
Aij =
{
1 if miRNA i targets gene j
0 otherwise
. (1)
The network is bi-partite, because there is no link be-
tween two elements within the group of genes or miR-
NAs, i.e. two genes or two miRNAs are never connected.
In Figure 2A, we have shown the distribution of tar-
gets (genes) Pg(n), which is the fraction of genes (shown
as circles in Figure 1) targeted by n number of miR-
NAs. If the connections had been random (i.e., if 676265
links were distributed among 711 miRNAs randomly) we
would have obtained a normal distribution (blue solid
line in Figure 2A). It is clear that Pg(n) varies signifi-
cantly from what is expected from a random bi-partite
graph. Pg(n) could be fitted to an exponential distribu-
tion (shown in the inset of Figure 2A) with a a typical
scale k∗ = 20. This implies that, most of the genes are
targeted by only k < 20 miRNAs. Only a few genes
are targeted by a large number (k ≥ 20) of miRNAs
which are termed as the target hubs. The degree dis-
tribution, being different from a random normal graph,
implies that there is a high organizational structure in
the gene-miRNA interaction network. Similar organi-
zational structure is observed from the distribution of
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Figure 2A: Distribution of targets Pg(k), which is fraction
of genes targeted by k miRNAs (red circles) is compared
with a random network (blue lines). The same plot is shown
in the inset in semi-logarithmic scale.
miRNAs Pm(k), which is the fraction of miRNAs that
target k number of genes. We find that 126 miRNA in
the miRNA hub target ≥ 1067 genes (data not shown).
Analysis of the genes in the target hub (total 9877,
Suplimentary table S1A) by PANTHER revealed that
genes with molecular functions like nucleotide binding,
transcription factor, receptor and hydrolase are enriched
compared with the genes in the human genome. Genes
involved in biological process like apoptosis, cell cy-
cle, developmental process, nucleic acid metabolism, sig-
nal transduction etc. are significantly over represented
among the genes in the target hub. Genes involved in
cell proliferation and differentiation, cell structure and
motility and oncogenesis are also significantly decreased.
Genes in the target hub are enriched in specific path-
ways like p53 pathway, angiogenesis, in two neurodegen-
erative disease pathways namely Alzheimers disease and
Huntingtons disease pathway. Representative result of
pathways enrichment is shown in the Figure 2B and the
full analysis is shown in the Supplementary table S1B
to S1D. Results shown in Supplementary table S1B to
S1D and in the Figure 2B indicate that miRNA in combi-
nation may alter molecular functions, biological processes
and cellular pathways. This result is similar to that have
been obtained with lesser number of miRNA (about 180)
that target approximately 10000 genes [20].
B. Micro RNA co-target network
To probe the detailed structure of the network, we cre-
ate a co-target network of miRNA-miRNA as follows : if
two miRNA co-target w (non-zero) number of genes, we
define that these miRNAs are linked. The weight of the
link is w. Otherwise, if w = 0, no connection is made be-
tween these miRNAs. By doing so, we form an undirected
weighted network of miRNAs. The corresponding adja-
cent matrix C is symmetric having elements Cij , where
Cij is the number of genes co-targeted by miRNA i and
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Figure 2B: Comparisons of various pathways in the human
genome and among the genes in the target hubs.
Representative pathways are shown where the genes in
specific pathways are significantly enriched (filled bars) in
comparison with that obtained in the human genome (open
bars) using PANTHER.
j.
C =


C11 C12 . . . . . . C1 711
C21 C22 . . . . . . C2 711
. . .
. . .
C711 1 C711 2 . . . . . . C711 711


(2)
The diagonal elements Cii, are not well defined. We take
Cii = 0. Schematic description of this network is shown
in the Figure 2C.
Few properties of this co-target network can be checked
easily. First, it is a “fully connected network”, which
does not have any sub-graph. The distribution of weights
Pg(w) is shown in Figure 2D, which is again compared
with corresponding random graph. The result indicates
that the connections are not random and the network
is highly organized. Again we find that there is a huge
difference between the maximum wight (Cij)max = 1253
and the minimum (Cij)min = 1, which leads to a con-
jecture that most links might be irrelevant and can be
erased. Next, we describe how to get an optimal set of
miRNAs, by erasing irrelevant links, which could still de-
scribe all essential features of the co-target network.
We define that the weak links are those whose weights
are smaller than a pre-decided cutoff q, and erase them.
(For example when q = 10, links between (1, 6) and
(710, 3) in Figure 2C are to be erased.) The network
do not remain fully connected anymore and breaks up
into smaller disconnected sub-graphs. Let the number
of these disconnected sub graphs be Nq, which explic-
itly depends on q. The largest among these subgraphs,
named as G, is the important sub-graph. Clearly size
of G decreases with increase of q. For very large q, G
has only fewer miRNAs; that might simply the study of
this network at the cost that some of the functionalities
4which are lost. Thus we need to optimize q such that all
irrelevant links are erased, keeping only the optimal set
of miRNAs in G which are functionally relevent. Note,
that the cut-off q redefines a new adjacency matrix
Cqij =
{
0 if Cij < q
1 otherwise
. (3)
Thus, the number of subgraphs Nq is the number of
diagonal blocks of Cq, which can be found by block-
diagonalizing the matrix Cq. Since it is a fully connected
graph, initially N1 = 1 and then Nq increases with q.
Figure 2D shows a plot of Nq versus q.
It is evident from Figure 2D that there are three
regimes, (a) q < q∗, (b) q ∼ q∗ and (c) q > q∗. Almost all
the connections are present in regime (a). In this regime
the connections are quite stiff and the network does not
break up until a threshold q = q∗ is reached. By increas-
ing q one goes to regime (b) where the irrelevant connec-
tions are already erased and only the relevant connections
are present. Thus any little change in q changes Nq sub-
stantially. The relevant miRNAs, which cooperatively
regulate the expressions of the genes to form the co-target
network are probably found in regime (b). In regime (c),
q is very large to erase even the relevant connections.
Only connections which are present in this regime (c) are
possibly due to chemical similarity, i.e, the miRNAs form
very small subgroups and seed sequences (position 2 to 7
in the mature miRNA) of miRNAs within a subgroup are
identical. This proposition has been verified as follows:
we take q = 600 and find all the disconnected sub-graphs
which have two or more miRNAs. The seed sequence of
miRNAs in every sub-group has been checked. We find
that the set of miRNAs in each subgroup (except only
one of 63 subgroups) have identical seed region [see sup-
plementary table S2].
Note that the continuous break-up transition is a dis-
tinct property of miRNA co-target network, it does not
occur for a random graph as shown in Figure 2D (blue
line). To emphasize this point further let us construct a
random undirected graph R which has total weight W is
same as that of C, i.e.,
W =
N∑
i=1
M∑
j=i+1
Cij = 10354685 =
N∑
i=1
M∑
j=i+1
Rij (4)
Effectively, we need to choose M(M − 1)/2 = 252050
random integers, one for each upper diagonal element of
C ( totalM(M−1)/2) so that their sum isW . Since the
random matrix R has to be symmetric (Rij = Rji), the
lower diagonal elements can be calculated by substitut-
ing Rij by Rji. In a similar way, by varying the cut-off q
we find Nq for R, which is shown in Figure 2D (as blue
dashed line). Note that the break up of the random net-
work into subgraphs in this case occurs discontinuously,
unlike the miRNA co-target network. This result indi-
cates that miRNA co-target network is structurally rich.
Details topological structure of the network are now be-
ing studied.
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Figure 2C: Representation of the miRNA network. Here
miRNAs (1 to 711) are shown in blue circles. In this
example C14 = 17 = C41 and C23 = 0 = C3,2, which says
that miRNA 1 and 4 co-target 17 genes whereas miRNA 2
and 3 do not have any common target.
The analysis reveals that the optimally connected
graph (the sub-graph having maximum number of rel-
evant miRNA nodes) which still posses the properties of
the network can be found if we work at q = q∗. To
find q∗, we differentiate q numerically with respect to
q. The maximum of d
dq
Nq (as shown in the Figure 2D)
corresponds to q∗ = 103. In this case, at q∗ = 103,
Nq = 166 and the largest connected sub graph G is found
to contain only 479 nodes (for full list of miRNAs in 166
sub graphs see the supplementary table S3). Thus, these
nodes or miRNAs form the optimal set of miRNA which
co-regulate the gene expressions. To determined how
miRNAs are organized within the sub graph G, we in-
crease the cutoff q beyond q∗ and follow how G as breaks
up into smaller clusters of miRNAs. Clusters in this con-
text are defined as the subgraph which has more than one
miRNAs. It is expected from Figure 2D that number of
such clusters would not change much once we reach re-
gion (c) where d
dq
Nq ≃ 0 which starts approximately at
q ≈ 160. Thus, we take q = 160 and collect the clusters
(the sub graphs of S which have two or more miRNAs).
There are in total 70 such clusters containing 330 miR-
NAs. Thus it is reasonable to assume that the miRNAs
within G are organized as 70 clusters, 169 independent
miRNAs and interactions between them. These clusters
form the basic units of the miRNA interaction network.
Figure 3 shows the interaction network of miRNA of 70
clusters. In the present study, we clustered the miRNAs
on the basis of their ability to co-target the same genes,
however, such co-targeting could be due to similarity in
the seed sequences. We checked that 18 out of 70 clus-
ters might be due to seed similarity. About 50% of the
miRNA in human are organized within 10Kb of genomic
50 300 600
q
0
300
600
N
q
103
dN
dq
(a)
(b)
q*
Figure 2D: (a) Number of disconnected sub-graphs Nq
when links with weight < q are erased. (b) corresponds to
the same, for a random network. Plot of d
dq
Nq (which is
scaled by a factor 20 for better visibility) shows a peak at
q∗ = 103.
sequence. Whether organizationally clustered miRNAs
are under same regulatory sequence and expressed to-
gether remains unknown. Eleven out of 70 clusters might
be due to the genomic organization(Supplementary table
S4).
We extended our analysis to study miRNA-
miRNA interaction networks in Caenorhabditis
elegans with 136 miRNAs and their 20366 targets
(http://microrna.sanger.ac.uk/cgi-bin/targets/v5/genome.pl).
The optimal value of q in this network is q∗ = 23. The
largest connected sub graph at q = q∗ contains 98
miRNAs. Most surprisingly, we find that both the
species show universal features near the breakdown
transition, similar to that shown for human in Figure 2D
(data not shown). Reasons for such similarity in break
down of miRNA-miRNA interaction network require
further studies.
It is also interesting to note that the clusters of miR-
NAs form a interaction network through their common
targets (shown in Figure 3 and discussed in section 4.4).
Biological significance of this network in under investiga-
tion.
C. Co-targeted genes in miRNA clusters may
involve in specific pathways
We need to know the biological relevance of the miRNA
clusters better as they form the basic units of biologi-
cal interactions for the regulation of the targets. The
smallest cluster in subgraph S, of course, contains two
miRNAs, while the largest cluster contains 47 miRNAs
(Supplementary table S4). To explore whether the miR-
NAs in clusters target genes in specific pathways we de-
termine if the co-targeted genes in a miRNA cluster is
involved in any specific pathway. To do so, we deter-
mine the common targets of the miRNAs in a cluster
taking two miRNA at a time, and then asked whether
Figure 3: Interaction network of 70 clusters containing 330
miRNAs ( links with weight < 2000 are erased).
the co-targeted genes are enriched for a particular path-
way(s) compared to the targets which are not co-targeted
by the miRNA in that cluster. For example, there are
three miRNAs in cluster no. 25 (supplementary ta-
ble S4), namely miR-603, miR-521 and miR-523, which
do not have common seed sequence and in combination
[miR-603 and miR-521 (n1) and miR-521 and miR-523
(n2) and mir-523 and miR-603 (n3)] target 449 genes
[(n1 + n2 + n3)]. These three miRNAs together target
2309 genes. The number of genes not targeted by the
miRNAs in this cluster is 1860. Using the PANTHER,
we observed that common targeted genes (449) are signif-
icantly (p ≤ 0.05) enriched in axon guidance mediated by
semamorphins (P00007), cell cycle (P00013), DNA repli-
cation (P00017) and FGF signaling (P00021) pathways.
This analysis further reveals that out of 70 clusters, co-
targeted genes in 47 clusters are significantly enriched at
least one biological pathway (total biological pathways in
human at PANTHER database is 153). In several cases,
the co-targeted genes are over represented in more than
one pathway (supplementary table S4). Significant en-
hancement of the genes co-targeted by the miRNAs in
a cluster indicate that these clustered miRNAs regulate
genes in specific pathway.
D. Involvement of clustered miRNAs in human
diseases
Alterations of several miRNAs have been observed ex-
perimentally in about eighty diseases [25]. To probe
whether the clustered miRNAs obtained above are as-
sociated with any disease, we retrieved data from pub-
lished papers, where deregulated miRNAs in diseases are
reported. We collected data for 15 diseases where dereg-
6ulation of miRNAs are reported (Supplementary table
S5, see supplementary text for the references). These
diseases include autism (number of deregulated miRNA
31), schizophrenia (22), diabetes (glucose homeostasis)
(19), ovarian cancer (54), AML (38), breast cancer (28),
colon cancer (19), lung cancer (39), pancreas cancer (56),
prostate cancer (48), stomach cancer (25), HNC (59),
thyroid cancer (51), CLL (53) and glioblastoma (11)
(Supplementary table S5). We note that total number
of miRNAs studied in these reports are not available for
all the cases, making it difficult to assign the miRNAs
which are not changed in these diseases. Among the al-
tered miRNAs, number of miRNAs in the largest cluster
G (479 miRNA) with q=103, and in the 70 clusters (S)
derived from the G with q = 160 is shown in the TABLE
I. It is evident from the table that for some diseases, the
numbers of miRNAs in G are significantly higher than
one expects from random distributions of the miRNAs
in clusters. For example, in prostate cancer, 48 miR-
NAs are deregulated, out of which 41 miRNAs belong
to the cluster G (479 miRNA). The expected number of
miRNA in this cluster is 32 (479× 48/711), which is sig-
nificantly lower from the observed value of 41 miRNA.
It is interesting to note that when the largest cluster G
was broken into 70 inter-connected clusters (S), the level
of significances of the miRNAs among 70 clusters than
the expected values (shown in TABLE I) are increased
considerably. This trend further justified the breaking of
the largest cluster/sub-graph G into smaller ones.
The miRNAs deregulated in the diseases are dis-
tributed among the 70 clusters in S and compared with
that was expected from random distributions. For ex-
ample, out of 28 miRNA deregulated in breast cancer,
18 miRNAs are distributed in 11 clusters (cluster # 3,
16, 20, 35, 37, 51, 57, 63, 64, 67 and 68, as shown in the
supplementary table S4) among the 70 clusters. Among
these 11 clusters, where 18 deregulated miRNAs are dis-
tributed, 8 clusters (cluster # 3, 16, 20, 35, 37, 51, 57
and 64, see supplementary table S4 for the clusters) have
significantly higher number of miRNA than that one ex-
pects from random distribution. Similarly, out of 22
miRNA deregulated in schizophrenia 18 miRNA in S are
distributed in 11 clusters. Among these 11 clusters only
8 clusters have significantly higher number of miRNA
than one expects. Distributions of miRNAs in differ-
ent clusters are significantly different from that expected
from random distributions. The representative result is
shown in the Figure 4 and the detailed result for all these
15 diseases are shown in the supplementary Figure SF1.
This result shows that significant numbers of deregulated
miRNAs in the diseases studied in this investigation be-
long to specific clusters. Only the clusters, which harbor
significantly higher number of miRNA over the random
distributions, are considered for further analysis (see next
section). Common targeted genes in different clusters are
significantly enriched in different pathways as shown in
the earlier section above.
Common targeted genes of the clusters 4, 55, 57 and 64
are enhanced in Huntingtons disease pathway (P00029).
Cluster 4 consists of miR-423-3p and miR-24. This clus-
ter 4 contains significantly more deregulated miRNA in
schizophrenia, colon cancer, pancreatic cancer, prostate
cancer, stomach cancer, head and neck cancer and thy-
roid cancer (supplementary Figure SF1) than expected
from the random distributions. This result indicates that
Huntingtons disease pathway might be deregulated in
these diseases. To search further if there is any exper-
imental proof for this proposition, we searched Hunting-
ton disease and Schizophrenia in pubmed. More than 300
references are found to contain both the terms. Evidence
that schizophrenia-like symptoms in Huntingtons disease
pedigree indicate that at molecular level the Huntingtons
disease pathway and schizophrenia might have some over-
lap (Corra et al., 2006). In Huntingtons disease (HD),
accelerated loss of striatal neurons by apoptotic death is
the major cellular event (Gil and Rego, 2008), while in
cancer cell death is prevented in general; apoptosis thus
might play opposite role in HD and cancer. Epidemiolog-
ical study indicates that the prevalence of cancer among
HD patients are less than that observed among individu-
als without HD (Sorensen et al., 1999). Knock out of p53
gene, a tumor suppressor gene and mutated in 50% of
the cancers, induces tumors in mice and decrease the life
span of the mice. Recently, it has been shown that the
expression of the mutant allele of HTT gene (expansion
of CAG repeats beyond 36 at the exon1 causes HD) pro-
longed the life of p53 knocked out mice. This observation
has been explained by the enhanced apoptosis induced
by the mutant HTT, which is likely to prevent cancer
(Ryan and Scrable, 2008). This result further indicates
that Huntington disease pathway may be altered in can-
cer. Our result that specific cluster of miRNA target this
pathway indicate that in cancer as well as schizophrenia
this pathway might be altered.
We further tested whether specific clusters of miRNA
are involved in specific disease. We collected the mRNA
expression data from the published literature for autism
(number of deregulated mRNA 795), schizophrenia (146)
and diabetes (189) [supplementary table S6 and supple-
mentary text]. Similar data for ovarian cancer (6219),
AML (5440), breast cancer (6100), colon cancer (932),
lung cancer (2747), pancreas cancer (6950), prostate can-
cer (4410), stomach cancer (589), HNC (5468), thyroid
cancer (3092), CLL (1967) and glioblastoma (6528) was
taken from ONCOMINE (http://www.oncomine.org/)
and determined whether deregulated genes are enriched
in specific pathway(s). Detailed result is shown in the
supplementary table S6. It is to be noted that only a
subset of these deregulated genes are likely to be dereg-
ulated by miRNAs. We compared the pathways that
are enriched for the deregulated genes in comparison to
that obtained among genes coded by human genom. in
microarray data with that are obtained for deregulated
miRNAs in these diseases and significantly enriched in
the clusters as described above. As mentioned above, in
breast cancer, 28 miRNAs are deregulated; 18 miRNA
7TABLE I: Significant number of miRNAs associated with any particular disease (known from published data) are present in
G. Even more significantly they belong to the subgroup group S consisting of cluster forming miRNAs.
Disease No of miRNAs No of miRNA in G No of miRNA in S
(from published data) (expected) [p-value] (expected) [p-value]
Autism 31 26 (21) [0.050] 20 (14) [0.043]
Schizophrenia 22 19 (15) [0.057] 18 (10) [0.001]
Diabetes 19 13 (13) [0.922] 9 (9) [0.933]
Overian Cancer 54 41 (36) [0.180] 32 (25) [0.058]
AML 38 29 (26) [0.240] 23 (18) [0.081]
Breast Cancer 28 23 (19) [0.095] 18 (13) [0.058]
Colon Cancer 19 13 (13) [0.922] 10 (9) [0.587]
Lung Cancer 39 28 (26) [0.556] 20 (18) [0.542]
Pancreas Cancer 56 41 (38) [0.351] 35 (26) [0.016]
Prostate Cancer 48 41 (32) [0.008] 38 (22) [0.000]
Stomach Cancer 25 18 (17) [0.621] 15 (12) [0.173]
HNC 59 50 (40) [0.004] 39 (27) [0.002]
Thyroid Cancer 51 40 (34) [0.092] 32 (24) [0.019]
CLL 53 44 (36) [0.015] 36 (25) [0.002]
Glioblastoma 11 9 (7) [0.307] 9 (5) [0.019]
AML: Acute Myeloid Leukemia, HNC : Head and Neck Cancer, CLL : Chronic Lymphocytic Leukemia
are distributed in 11 clusters among the 70 clusters of
which 8 clusters harbors miRNAs significantly over the
random distribution. Common targeted genes in these
8 clusters are over represented in 12 unique biological
pathways (total 13 pathways, supplementary table S7).
We then compared the pathways that are enriched for
the deregulated genes and observed that 10 unique path-
ways are common. Common pathways that are enriched
in the specific clusters of miRNAs and deregulated genes
in diseases further indicate that the specific clusters of
miRNA are likely to target specific pathway(s) and in-
volve in diseases.
Significance of “co-targeting the genes” by miRNA is
not clear and requires further investigations. Limited ex-
perimental evidences indicate that miRNA influences the
expressions of the targets moderately (Lim et al., 2005,
Selbach et al., 2008) and proposed to be involved in fine-
tuning of gene expressions (Flynt and Lai, 2008). Thus,
in combination, the level of expression of target genes of
miRNA might reduce further the gene expression com-
pared to that could be obtained with a single miRNA.
Combinational regulation of target genes by miRNAs
might be complicated by the location of the target sites
at 3′ UTR as well as the tissue specific expressions of the
miRNAs. There are overlapping or very closely spaced
miRNA target sites for a particular target gene. Such
target gene might not have additional effects of the sec-
ond miRNA due to physical hindrance of the target site
by binding of the other miRNA at the near by or over-
lapping site. The same gene may be targeted by different
miRNA, when the miRNA expression is regulated at the
tissue level.
In our analysis seventy clusters of miRNA contains all
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Figure 4: Distribution of deregulated miRNAs in breast
cancer (29). 19 out of 29 miRNAs are distributed in 11
clusters. Significant increase is found only in 8 cluster ( #
3, 16, 20, 35, 37, 51, 57, 64).
together 330 miRNA and each cluster contains has than 2
miRNA. Out of these 70 clusters, 18 clusters could arise
due to the seed similarities and 11 clusters could arise
for genomic organization (co-localized). Among these
clusters, 4 clusters are common for the seed similarity
and co-localization (Supplementary table S4). It is in-
teresting to note that out of 18 clusters, which could
arise due to seed sequence similarity, only 5 clusters are
associated with pathways, which are enriched with co-
targeted genes. Two clusters (#26 and #31) that could
arise from seed sequence similarity and co localization,
also associated with co-targeted genes enriched in spe-
8cific pathways. This result indicates that in the major-
ity of cases, clustered miRNA did not arise due to seed
sequence similarity. Co-targeted genes in the miRNA
cluster and enriched in specific pathways for 5 clusters
could arise from co-localization of the miRNAs in the
genomic regions. These miRNAs, which are co local-
ized in the same chromosomal region (with in 10Kb up-
stream and down stream of the pre-miRNA) might be
regulated by the same promoter regions and co-expressed
together. In a recent study, miRNAs hsa-mir-92a-1,hsa-
mir-20a, hsa-mir-18a,hsa-mir-17,hsa-mir-19b-1 and hsa-
mir-19a, which are co localized on chromosome 13 within
10kb, have been shown to act in a combinatorial fashion.
The authors explained that in combination, the miRNA
down regulated to the measurable extent, while individ-
ual miRNA was unable to down regulate the target suffi-
ciently [21]. This result also support the notion that miR-
NAs in combination lowers the expressions than an indi-
vidual miRNA. In the majority (47/70) of the miRNA
clusters, co-targeted genes are enriched in at least one
pathway. Out of 153 pathways described in the PAN-
THER (total number of genes 25431, total number path-
way hit in 7151, thus one gene is involved in more than
one pathways), 105 distinct pathways are enriched with
the co-targeted genes in 47 clusters. Among these 47
clusters, 28 clusters contain significantly excess deregu-
lated miRNAs in diseases. Co-targeted genes in these 28
clusters are enriched in 72 distinct pathways. Same path-
way appeared in multiple times in different diseases, alto-
gether 72 pathways appeared 359 times in diseases. For
example, Huntingtons disease pathway (P00029) appears
19 times in 15 diseases indicating the importance of this
pathway in several diseases. The miRNA clusters where
co-targeted genes are enriched in this particular path-
way and also harbors significantly higher deregulated
miRNA in diseases are 4 (423-3p, miR-24), 33 (miR-
149, miR-892b), 52 (miR-508-5p, miR-516a-3p, miR-198,
miR-520a-5p, miR-517*, miR-525-5p, miR-516b, miR-
518c*, miR-518e*, miR-518d-5p, miR-518f*), 55 (miR-
373*, miR-616*, miR-888), 64 (miR-331-3p, miR-146b-
3p, miR-18b*, miR-18a*, miR-324-5p, miR-874, miR-
324-3p, miR-10a, miR-10b). These miRNAs are likely
to target 172 genes in Huntington disease pathway and
participates in the diseases discussed in this manuscript.
It is interesting to mention, although significance if any
remains unknown, that Huntingtons disease pathway was
also over represented among the genes at the target hub
as described in earlier section. Experimental verification
to substantiate of the contention that miRNAs in the
clusters together alter this pathway is necessary to con-
firm the prediction.
III. CONCLUSION
In conclusion, we constructed a miRNA-miRNA
weighted interaction network using 711 miRNAs and
their predicted targets. A novel method was applied to
break up the network into smaller sub graphs (clusters).
We further extended our studies to show that specific
clusters of miRNA might be involved in specific pathways
that are known/predicted in several diseases. We pro-
pose that instead of a single miRNA, a group of miRNA
together target genes in specific pathway and the interac-
tions of these clusters are likely to be involved in diseases.
IV. METHOD
A. Data mining
All the miRNA and the predicted targets are down-
loaded from miRBase (http://microrna.sanger.ac.uk/,
version 10). In version 10 of this database, there are 711
miRNAs coded by 533 genomic loci. This is because,
double stranded miRNA produced by DICER and other
protein is separated by helicase, and in some cases
both the strands can act as the mature single stranded
miRNA. In general, the expression of one of the strand is
more than the others. The strand, which expresses less,
is denoted by mir*. Predicted numbers of transcript
(mRNA) that are targeted by this 711 miRNA is 34525.
It is to be noted that total number of human genes in
PANTHER is 25431. Thus, it is likely that the some of
the targets of miRNA in the Sanger database may actu-
ally be the isoform of the genes. All the predicted targets
of miRNA in miRBase are identified with the ENSEM-
BLE ID (http://www.ensembl.org/). For analysis with
different data bases, the IDs are converted into NCBI
gene IDs by using the site Clone/Gene Id Converter
(http://idconverter.bioinfo.cnio.es/) and Ensemble
Genome Browser (http://www.ensembl.org/index.html).
Genes which are down regulated or up regulated
in various cancers are downloaded from ONCOMINE
(http://www.oncomine.org/). For other diseases, we col-
lected the deregulated genes from various published data.
ONCOMINE provides the gene names/symbols. These
gene names are converted into the NCBI gene Id (NM
numbers) by using the site Clone/Gene Id Converter
(http://idconverter.bioinfo.cnio.es/) and by using vari-
ous web sites as mentioned above. The deregulated miR-
NAs in different diseases are also collected from the dif-
ferent published data. Full references are provided in the
supplementary text.
B. Formation of network
We use in house perl scripts to convert the dataset con-
taining 711 miRNAs and their targets into adjacency ma-
trix Aij (see text) by giving arbitrary, but unique, iden-
tification numbers to genes as i = 1, 2 . . .N and miRNAs
as j = 1, 2 . . .M respectively. Aij may take value 1 if
gene i contains a predicted recognition site for miRNA j
in the 3′ UTR or otherwise Aij = 0. Corresponding net-
work is shown in Figure 1, where all the genes (miRNAs)
9are represented as red(blue) circles and a line (joining
blue circle j red circlei) is drawn if Aij = 1.
Further, matrix A is used for constructing a miRNA
co-target network. Two miRNAs j and k are said to
be connected if they have at least one common target.
Weight of the connection or link is defined to be Cjk,
which is simply the number of common targets of miRNA
j and k. Matrix C has dimesion 711× 711, which can be
constructed from A as C = ATA, where transpose of A
is defined as (AT )ji = Aij . Or in otherwords,
Cjk =
∑
i
AijAik. (5)
C. Clustering of miRNAs in miRNA co-target
network
Since the miRNA co-target network is fully connected
with large number of links having very small weights, we
would like to get rid of these links and find sub-graph
which contains only relevent miRNAs. This can be done
by erasing the weak links, say the links which has weight
less than a cutoff q. The network, then breaks up into
several disconnected sub-graphs, in total Nq. Thus, Nq
is just the number of diagonal blocks of matrix C, which
was calculated using an in house C program. Nq changes
marginally as q is increased and then a rapid change oc-
curs at q = q∗. It is assumed that the network breaks
rapidly as the relevent (or most significant) links are re-
moved. To find q∗, we differentiate Nq with respect to
q numerically and find the peak position, which corre-
sponds to the q value where the change is maximum.
Now we fix q = q∗ and find the largest sub-graph G
among Nq∗ subgraphs. G is considered to be the rele-
vant. To know, how the miRNAs are arranged within G
we further increase q to 160 (see text for the explanation
on why we choose q = 160) and collect the subgraphs of
G. The sub-graph G containing more than one miRNA
are called clusters.
D. Network of miRNA clusters
To get a network of miRNA clusters, first we get the
weight Wmn of the link between cluster m and n. Let
cluster m (n) has Nm ( Nn) miRNAs. We add the
weights(no of co-targets) of every pair miRNA, fromed
by taking one miRNA from cluster m and the other from
cluster n, and define the sum to be the weight of the link.
Thus, W forms a (70× 70) matrix with elements
Wmn =
∑
i∈m
∑
j∈n
Cij . (6)
The diagonal elements Wnn are non-zero and it indicates
the strength of the cluster which is the total number of
pair-wise co-targets of the cluster n. There is no natural
cutoff on the weights as they show a scale free distribution
(data not shown). We take an arbitrary cutoff 2000 to
draw the network, i.e, a link is drawn between cluster m
and n only if Wmn > 2000.
E. Co-targeted genes in miRNA clusters
For the identification of target genes in a specific clus-
ter, we first find the co-targeted genes pair wise in a clus-
ter. For example, if there are three miRNA like miR-1,
miR-2 and miR-3 (hypothetical) are in a cluster, the pre-
dicted common targets of the miRNAs are those, which
are common for miR-1 and miR-2 (n1), miR-2 and miR-
3 (n2), miR-1 and miR-3 (n3). The pathway(s) where
these common targets (n = n1 + n2 + n3) belong are ob-
tained from the PANTHER. This result was compared
with that obtained with those targets, which are not com-
mon (m−n in total, wherem is the total predicted targets
of miR-1, miR-2 and miR-3).
F. Classification of the genes in target hub,
co-targeted by miRNA in clusters, deregulated in
diseases using PANTHER and enhancement analysis
In PANTHER (Protein Analysis Through Evolution-
ary Relationships), genes are classified on the basis
of their functions using published experimental obser-
vations and evolutionary relationships; in the absence
of direct experimental evidence. Proteins are classi-
fied by expert biologists and categorized by molecular
function and biological process and biological pathways
(http://www.pantherdb.org/). In miRNA target search,
targets are identified with the Ensemble IDs that con-
tains several isoforms of the genes. We omitted these iso-
forms as well as other Ensemble IDs for which we are un-
able to retrieve the Gene symbols for PANTHER analy-
sis. To identify, whether genes in target hub, co-targeted
by miRNA in clusters and deregulated in diseases when
classified on the basis of molecular functions, biological
processes and pathways are over represented (enhanced)
in particular category in comparison with that obtained
in the human genome we analyzed the genes using the
PANTHER. If the fraction of genes in the test samples
are significantly enriched in a particular category over
that obtained in the human genome, we consider the
specific category is involved/associatedwith the test sam-
ples. For example, if the co-targeted genes in a particular
cluster are significantly over represented in Wnt signal-
ing pathway (PANTHER ID P00057), we consider that
this cluster was associated with this pathway.
Deregulated expressions of genes observed in several
diseases discussed in this manuscript which are taken
from published literature are analyzed using PANRHER.
Significant (p values less than 0.05) increase in genes in
specific pathways in comparison with that of the human
genom are identified.
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G. Correlation of miRNAs in clusters and diseases
From the published literature we collected 15 diseases
where the deregulation of several miRNAs are reported.
We then ask: what fraction these reported miRNAs, say
n in total, are distributed among the 70 different clus-
ters (obtained at q = 160, see text for details). This
fraction is then compared with the random distribution
of n miRNAs among 70 clusters. Those clusters hav-
ing miRNAs significantly larger (with p values less than
0.05) than that of a random distribution are considered
relevant for this particular disease. Significantly enriched
genes in pathways, identified from common miRNA tar-
geted genes in these relevant clusters, are compared with
the pathways of significantly enriched genes observed in
deregulated mRNAs (from micro-array data).
H. Comparisons of the pathways between those
observed in common targeted genes in clusters and
that of in deregulated mRNA in diseases
From ONCOMINE and published literature we col-
lected the deregulated genes in 15 diseases and ana-
lyzed using PANTHER. Significantly altered pathways
are identified. These are then compared with the path-
ways obtained in common targeted genes in clusters.
I. Statistical analysis
Calculation of p value can be best described with an
example. If n = 11 is the number of miRNA present
in a cluster among total N = 330 miRNA, and for
a particular disease there are only m = 2 miRNAs
in that cluster among total M = 30 miRNAs, then
χ2 = (mN/M − n)2[1/n + 1/(N − n)], which is 11.38
in this example. p value is the probability that x > χ2 in
chi-square distribution Q(x). Thus, p = 1 −
∫ χ2
0
Q(x)dx
which can be readily integrated using Mathematica or
by reading it from a Table. In this example p = 0.00074.
Note that p < .050 is equivalent to χ2 > 3.841.
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VI. SUPPLEMENTARY MATTERIAL
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get the Supplementary Matterial.
A. Supplementary tables
Table S1: List of the genes that targeted by more than
20 miRNAs (target hub) [S1A]. Genes at target hub are
classified using PANTHER according to molecular func-
tions, biological processes and biological pathways and
compared with that obtained with the human genome
(S1 B, S1C and S1D).
Table S2: List of the miRNAs that have same seed re-
gions (position 2 to 7 in the mature miRNA) nucleotides
of the the mature miRNAs.
Table S3: List of miRNAs in 166 sub graphs which
are found at q∗ = 103.
Table S4: List of 70 clusters and the miRNAs be-
longing to each cluster, seed sequence similarity, genomic
organization (only those which are clustered together
within 10kb genomic region are only noted). In a clus-
ter, the common targets for each pair of miRNA is deter-
mined and added. Biological pathways for the common
targets in comparisons with the total targets that are not
common are compared. Only the pathways that are sig-
nificantly (less than equal to 0.05) enriched in the targets
are shown.
Table S5: Experimentally observed deregulated miR-
NAs in 15 different diseases are shown. For references of
the sources of these miRNA please see the supplementary
text.
Table S6: Analysis of deregulated genes in 15 differ-
ent diseases is shown. For references of the sources of the
experimentally determined deregulated genes please see
the supplementary text.
Table S7: Significantly enhanced genes in pathways
for altered mRNA is listed for 15 different diseases. Those
pathways which are common to the pathways predicted
from the miRNA clusters are marked (in red).
B. Supplementary Figures
SF1: Distributions of various experimentally deter-
mined deregulated miRNAs among 70 clusters of miR-
NAs
C. Supplementary Text
References of the literature from where we have col-
lated the deregulated miRNA and genes.
